Showing results (181-190 of 210) with videos related to
Sort By:
Pageof 21
European Heart Journal|October 18, 2003
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trialS Savonitto, P W Armstrong, A M Lincoff, et al.Journal of the American College of Cardiology|June 1, 1996
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 InvestigatorsL K Newby, W R Rutsch, R M Califf, et al.Circulation|July 9, 2003
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarctionL Wallentin, P Goldstein, P W Armstrong, et al.Heart (British Cardiac Society)|June 17, 2005
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patternsP Kaul, L K Newby, Y Fu, et al.The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.Clinical Chemistry|March 25, 1998
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa InvestigatorsR H Christenson, S H Duh, L K Newby, et al.Journal of the American College of Cardiology|January 15, 2000
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarctionD Hasdai, R M Califf, T D Thompson, et al.Journal of the American College of Cardiology|September 19, 1998
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary ArteriesM Pfisterer, J L Cox, C B Granger, et al.European Heart Journal|April 1, 1999
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary ArteriesD Hasdai, D R Holmes, E J Topol, et al.The New England Journal of Medicine|March 16, 2000
Cost effectiveness of early discharge after uncomplicated acute myocardial infarctionL K Newby, E L Eisenstein, R M Califf, et al.Pageof 21